Table 4.
HPV genotypes characterization across all cytological grades of cases and controls
HIV status | HPV types | Cytological grades | Total | P-Value | |||
---|---|---|---|---|---|---|---|
NORMAL n (%) | ASCUS n (%) | LSIL n (%) | HSIL n (%) | ||||
+VE (Cases) | 16 | 2 (2.4) | 2 (2.4) | 1 (1.2) | 9 (10.7) | 14 (16.6) | 0.0002 |
-VE (Controls) | 16 | 2 (2.4) | 0 (0.0) | 5 (6.0) | 5 (6.0) | 12 (14.2) | |
+VE (Cases) | 16,18/45 | 0 (0.0) | 1 (1.2) | 3 (3.6) | 6 (7.1) | 10 (11.9) | 0.001 |
-VE (Controls) | 16,18/45 | 0 (0.0) | 4 (4.8) | 5 (6.0) | 0 (0.0) | 9 (10.7) | |
+VE (Cases) | 16,18/45,P3 | 0 (0.0) | 0 (0.0) | 1 (1.2) | 1 (1.2) | 2 (2.4) | 0.444 |
+VE (Cases) | 16,18/45,P3,P4 | 0 (0.0) | 0 (0.0) | 1 (1.2) | 4 (4.8) | 5(6.0) | 0.333 |
+VE (Cases) | 16,18/45,P3,P5 | 0 (0.0) | 1 (1.2) | 0 (0.0) | 0 (0.0) | 1 (1.2) | <0.0001 |
+VE (Cases) | 16,P3,P5 | 0 (0.0) | 0 (0.0) | 1 (1.2) | 0 (0.0) | 1 (1.2) | <0.0001 |
+VE (Cases) | 16,P5 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.2) | 1 (1.2) | <0.0001 |
+VE (Cases) | 18/45 | 2 (2.4) | 1 (1.2) | 0 (0.0) | 1 (1.2) | 4 (4.8) | 0.282 |
-VE (Controls) | 18/45 | 0 (0.0) | 2 (2.4) | 4 (4.8) | 1 (1.2) | 7 (8.3) | |
+VE (Cases) | 18/45,P3 | 0 (0.0) | 0 (0.0) | 2 (2.4) | 0 (0.0) | 2 (2.4) | 0.444 |
+VE (Cases) | 18/45,P3,P4 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.2) | 1 (1.2) | <0.0001 |
+VE (Cases) | P3 | 0 (0.0) | 1 (1.2) | 0 (0.0) | 0 (0.0) | 1 (1.2) | <0.0001 |
-VE (Controls) | 16,18/45,P4 | 0 (0.0) | 2 (2.4) | 2 (2.4) | 0 (0.0) | 4 (4.8) | 0.14 |
-VE (Controls) | 18/45,P4 | 0 (0.0) | 2 (2.4) | 4 (4.8) | 1 (1.2) | 7 (8.3) | 0.282 |
-VE (Controls) | P4 | 0 (0.0) | 0 (0.0) | 2 (2.4) | 0 (0.0) | 2 (2.4) | 0.444 |
-VE (Controls) | 16,P4 | 0 (0.0) | 0 (0.0) | 1 (1.2) | 0 (0.0) | 1 (1.2) | <0.0001 |
P denotes Pooled types categories of HR-HPVs; P3 are types (31, 33, 35 52 or 58), P4 (51 or 59) and P5 (39, 56, 66 or 68)